Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-arginine in arterial hypertension
NCT04626375Phase 4Completed
- Sponsor
- University of Naples Federico II
- Start
- Sep 2020
- Primary completion
- Aug 2021
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of arginine in hypertension (HTN), myocardial dysfunction, sponsored by University of Naples Federico II. Started Sep 2020; status: completed.
02
Drugs
arginine
03
Conditions
hypertension (HTN)myocardial dysfunction
Beyond the preview
Go deeper on NCT04626375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04626375.